Clinical Trial Update: Averting Complications of Proton Pump Inhibitor Therapy by Effervescent Calcium Magnesium Citrate [Phase 3]

View source ↗

Summary

Phase 3 trial investigating effervescent calcium magnesium citrate to avert complications of long-term proton pump inhibitor therapy; study terminated with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypomagnesemia
• Osteoporosis

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Osteoporosis, Hypomagnesemia | Phase 3 | Status: TERMINATED | Results posted: 2022-08-17